FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113485312> ?p ?o ?g. }

• W2113485312 endingPage "1190" @default.
• W2113485312 startingPage "1184" @default.
• W2113485312 abstract "To evaluate the impact of the quality of involved-field radiotherapy (IFRT) on clinical outcome in patients with advanced Hodgkin's lymphoma (HL) in complete remission (CR) after six to eight cycles of mechlorethamine, vincristine, procarbazine, prednisone-doxorubicin, bleomycin, and vinblastine (MOPP-ABV) chemotherapy.A retrospective review of clinical and radiologic data, radiation charts, simulator films, and megavoltage (MV) photographs was performed. IFRT consisted of 24 Gy to all initially involved nodal areas and 16-24 Gy to all initially involved extranodal sites. Major violations were defined as no or only partial irradiation of an originally involved area, or a total dose <90% of the prescribed dose.Of the 739 patients who were enrolled in the trial between 1989 and 2000, 57% achieved a CR; 152 of 172 patients randomized to IFRT actually received radiotherapy; and in 135 patients, quality control was performed. The overall major violation rate was 47%, predominantly concerning target volumes. The total dose was correct in 81% of the patients. After a median follow-up of 6.5 years, there was no difference in cumulative failure rate between patients with or without major violations. There was no relationship between incidence or site of relapse and major protocol violations.In advanced-stage HL patients in complete remission after six to eight cycles of MOPP-ABV, the outcome was not influenced by violation of the radiotherapy protocol." @default.
• W2113485312 created "2016-06-24" @default.
• W2113485312 creator A5000544997 @default.
• W2113485312 creator A5005494079 @default.
• W2113485312 creator A5006802021 @default.
• W2113485312 creator A5010078471 @default.
• W2113485312 creator A5011615789 @default.
• W2113485312 creator A5022864667 @default.
• W2113485312 creator A5023992858 @default.
• W2113485312 creator A5024839948 @default.
• W2113485312 creator A5025051235 @default.
• W2113485312 creator A5026185552 @default.
• W2113485312 creator A5029086405 @default.
• W2113485312 creator A5030811791 @default.
• W2113485312 creator A5030988280 @default.
• W2113485312 creator A5064102980 @default.
• W2113485312 creator A5067948995 @default.
• W2113485312 creator A5072078840 @default.
• W2113485312 creator A5076421255 @default.
• W2113485312 creator A5089561203 @default.
• W2113485312 date "2005-11-01" @default.
• W2113485312 modified "2023-09-26" @default.
• W2113485312 title "Quality control of involved-field radiotherapy in patients with advanced Hodgkin’s lymphoma (EORTC 20884)" @default.
• W2113485312 cites W1828835859 @default.
• W2113485312 cites W1982346408 @default.
• W2113485312 cites W2019994640 @default.
• W2113485312 cites W2065620512 @default.
• W2113485312 cites W2065848721 @default.
• W2113485312 cites W2070266446 @default.
• W2113485312 cites W2084207940 @default.
• W2113485312 cites W2092192760 @default.
• W2113485312 cites W2111280086 @default.
• W2113485312 cites W2128719630 @default.
• W2113485312 cites W2261080275 @default.
• W2113485312 cites W2262902984 @default.
• W2113485312 cites W2270174618 @default.
• W2113485312 doi "https://doi.org/10.1016/j.ijrobp.2005.03.044" @default.
• W2113485312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15936157" @default.
• W2113485312 hasPublicationYear "2005" @default.
• W2113485312 type Work @default.
• W2113485312 sameAs 2113485312 @default.
• W2113485312 citedByCount "20" @default.
• W2113485312 countsByYear W21134853122012 @default.
• W2113485312 countsByYear W21134853122013 @default.
• W2113485312 countsByYear W21134853122014 @default.
• W2113485312 countsByYear W21134853122015 @default.
• W2113485312 countsByYear W21134853122016 @default.
• W2113485312 countsByYear W21134853122022 @default.
• W2113485312 crossrefType "journal-article" @default.
• W2113485312 hasAuthorship W2113485312A5000544997 @default.
• W2113485312 hasAuthorship W2113485312A5005494079 @default.
• W2113485312 hasAuthorship W2113485312A5006802021 @default.
• W2113485312 hasAuthorship W2113485312A5010078471 @default.
• W2113485312 hasAuthorship W2113485312A5011615789 @default.
• W2113485312 hasAuthorship W2113485312A5022864667 @default.
• W2113485312 hasAuthorship W2113485312A5023992858 @default.
• W2113485312 hasAuthorship W2113485312A5024839948 @default.
• W2113485312 hasAuthorship W2113485312A5025051235 @default.
• W2113485312 hasAuthorship W2113485312A5026185552 @default.
• W2113485312 hasAuthorship W2113485312A5029086405 @default.
• W2113485312 hasAuthorship W2113485312A5030811791 @default.
• W2113485312 hasAuthorship W2113485312A5030988280 @default.
• W2113485312 hasAuthorship W2113485312A5064102980 @default.
• W2113485312 hasAuthorship W2113485312A5067948995 @default.
• W2113485312 hasAuthorship W2113485312A5072078840 @default.
• W2113485312 hasAuthorship W2113485312A5076421255 @default.
• W2113485312 hasAuthorship W2113485312A5089561203 @default.
• W2113485312 hasConcept C126322002 @default.
• W2113485312 hasConcept C126838900 @default.
• W2113485312 hasConcept C143998085 @default.
• W2113485312 hasConcept C146357865 @default.
• W2113485312 hasConcept C151730666 @default.
• W2113485312 hasConcept C2776232574 @default.
• W2113485312 hasConcept C2776305933 @default.
• W2113485312 hasConcept C2776694085 @default.
• W2113485312 hasConcept C2776755627 @default.
• W2113485312 hasConcept C2777132456 @default.
• W2113485312 hasConcept C2778720950 @default.
• W2113485312 hasConcept C2779112685 @default.
• W2113485312 hasConcept C2779429289 @default.
• W2113485312 hasConcept C2989005 @default.
• W2113485312 hasConcept C509974204 @default.
• W2113485312 hasConcept C71924100 @default.
• W2113485312 hasConcept C72563966 @default.
• W2113485312 hasConcept C86803240 @default.
• W2113485312 hasConcept C88879693 @default.
• W2113485312 hasConceptScore W2113485312C126322002 @default.
• W2113485312 hasConceptScore W2113485312C126838900 @default.
• W2113485312 hasConceptScore W2113485312C143998085 @default.
• W2113485312 hasConceptScore W2113485312C146357865 @default.
• W2113485312 hasConceptScore W2113485312C151730666 @default.
• W2113485312 hasConceptScore W2113485312C2776232574 @default.
• W2113485312 hasConceptScore W2113485312C2776305933 @default.
• W2113485312 hasConceptScore W2113485312C2776694085 @default.
• W2113485312 hasConceptScore W2113485312C2776755627 @default.
• W2113485312 hasConceptScore W2113485312C2777132456 @default.
• W2113485312 hasConceptScore W2113485312C2778720950 @default.
• W2113485312 hasConceptScore W2113485312C2779112685 @default.

• next